PRM60 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for 1st- Line Chronic Myeloid Leukaemia

✍ Scribed by Hoyle, M.; Pavey, T.; Ciani, O.; Crathorne, L.; Jones-Hughes, T.; Cooper, C.; Osipenko, L.; Venkatachalam, M.; Rudin, C.; Ukoumunne, O.; Garside, R.; Anderson, R.

• Book ID: 122117030
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 56 KB
• Volume: 15
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2012.08.1523